Fibrilação Atrial: Artigos de Revisão Online (Atrial Fibrillation: Online Review Articles)

■ Antiarrhythmic drugs for atrial fibrillation: imminent impulses are emerging

Gheorghe-Andrei Dan, Dobromir Dobrev

Int J Cardiol Heart Vasc. 2018 Dec; 21: 11–15.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138883/

■ 2018 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation

J G Andrade, A Verma, L B Mitchell et al

Canadian Journal of Cardiology 2018, vol 34 (11): 1371-1392

https://www.onlinecjc.ca/article/S0828-282X(18)31062-6/fulltext

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Hugh Calkins, Gerhard Hindricks, Riccardo Cappato et al

Europace. 2018 Jan; 20(1): e1–e160

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834122/

■ Integrating new approaches to atrial fibrillation management: the 6^th AFNET/EHRA Consensus Conference

D Kotecha, G Breithardt, A J C Gregory

EP Europace 2018, vol 20 (3): 395-407

https://academic.oup.com/europace/article/20/3/395/4782691

■ Digoxin for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials

Naqash J. Sethi, Emil E. Nielsen, Sanam Safi et al

PLoS One. 2018; 13(3): e0193924

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843263/

■ Atrial fibrillation and hyperthyroidism: a literature review

Vivek Reddy, Wael Taha, Shanker Kundumadam, Mazhar Khan

Indian Heart J. 2017 Jul-Aug; 69(4): 545–550

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560908/

■ Calcium in the pathophysiology of atrial fibrillation and heart failure

Nathan C. Denham, Charles M. Pearman, Jessica L. Caldwell et a

Front Physiol. 2018; 9: 1380

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180171/

■ Risk factor management in atrial fibrillation

Axel Brandes, Marcelle D Smit, Bao Oanh Nguyen et a

Arrhythm Electrophysiol Rev. 2018 Jun; 7(2): 118–127

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020195/

■ Is epicardial fat tissue associated with atrial fibrillation

analysis

Alireza Sepehri Shamloo, Nikolaos Dagres, Boris Dinov et al

Int J Cardiol Heart Vasc. 2019 Mar; 22: 132–138

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356021/

■ Mechanisms of atrial fibrillation in athletes: What we know and what we do not know?

Guasch, L. Mont, M. Sitges

Neth Heart J. 2018 Mar; 26(3): 133–145

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818379/

■ Oral anticoagulation in chronic kidney disease and atrial fibrillation: the use of non-vitamin K-dependent anticoagulants and vitamin K antagonists

Gunnar H. Heine, Vincent Brandenburg, Stephan H. Schirmer

Dtsch Arztebl Int. 2018 Apr; 115(17): 287–294

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974258/

■ Direct oral anticoagulant for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations

Zachary A. Stacy, Sara K. Richter

Ther Adv Cardiovasc Dis. 2018 Sep; 12(9): 247–26

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116754/

■ Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!

S. Jacobs, R. G. Tieleman

Neth Heart J. 2018 Jun; 26(6): 334–340.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968007/

■ Periprocedural anticoagulation in atrial fibrillation: update on electrical cardioversion and ablation

P. G. van Vugt, M. A. Brouwer

Neth Heart J. 2018 Jun; 26(6): 352–360

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968006/

■ Inflammation and atrial fibrillation: a comprehensive review

Panagiotis Korantzopoulos, Konstantinos P. Letsas, Gary Tse, Nikolaos Fragakis et al

J Arrhythm. 2018 Aug; 34(4): 394–401

https://onlinelibrary.wiley.com/doi/full/10.1002/joa3.12077

■ Atrial fibrillation and cryptogenic stroke. What is the current evidence? Role of electrocardiographic monitoring

Raimundo Carmona‐Puerta, Yaniel Castro‐Torres

J Arrhythm. 2018 Feb; 34(1): 1–3

■ 2018 Korean guideline of atrial fibrillation management

Boyoung Joung, Jung Myung Lee, Ki Hong Lee et al

KHRS Atrial Fibrillation Guideline Working Group

Korean Circ J. 2018 Dec; 48(12): 1033–1080

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221873/

■ Oral anticoagulation in chronic kidney disease and atrial fibrillation: the use of non-vitamin K-dependent anticoagulants and vitamin K antagonists

Gunnar H. Heine, Vincent Brandenburg, Stephan H. Schirmer

Dtsch Arztebl Int. 2018 Apr; 115(17): 287–294

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974258/

■ Ablation of atrial fibrillation: facts for the referring physician

A R M Sridhar, O Wazni, A A Hussein

Cleveland Clinic Journal of Medicine 2018, vol 85 (10) 789-799

https://www.mdedge.com/ccjm/article/175643/cardiology/ablation-atrial-fibrillation-facts-referring-physician

■ Predisposing factors for atrial fibrillation in the elderly

Kristina Wasmer, Lars Eckardt, Günter Breithardt

J Geriatr Cardiol. 2017 Mar; 14(3): 179–184

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460064/

■ Oral anticoagulante in older patient with atrial fibrillation: a systematic and meta-regression analysis

Y Bai, S Guo, H Deng et al

Age and Ageing 2018, vol 47 (1): 9-17

https://academic.oup.com/ageing/article/47/1/9/4107850

■ Atrial fibrillation: the current epidemic

Carlos A Morillo, Amitava Banerjee, Pablo Perel, David Wood, Xavier Jouven

J Geriatr Cardiol. 2017 Mar; 14(3): 195–20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460066/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828277/

■ Adenosine-guided radiofrequency catheter ablation of atrial fibrillation. A meta-analysis of randomized control trials

Konstantinos P. Letsas, Stamatis Georgopoulos, Michael Efremidis et al

J Arrhythm. 2017 Aug; 33(4): 247–255

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529608/

■ Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes

Laila Staerk, Jason A. Sherer, Darae Ko, Emelia J. Benjamin

Robert H. Helm

Circ Res. 2017 Apr 28; 120(9): 1501–1517

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500874/

■ Apixaban to prevent stroke in patients with atrial fibrillation: a review

Benjamin E. Peterson, Sana M. Al-Khatib, Christopher B. Granger

Ther Adv Cardiovasc Dis. 2017 Mar; 11(3): 91–104

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942796/

■ European Heart Rhythm Association (EHRA)/European Association Cardiovascular Prevention and Rehabilitationn (EACPR) position paper on how to prevent atrial fibrillation endordes by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

EHRA Scientific Committee Task Force, Bulent Gorenek

Antonio Pelliccia, Emelia J. Benjamin et al

Eur J Prev Cardiol. 2017 Jan; 24(1): 4–40.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427484/

■ Reducing the risk of stroke in eldely patients with non-valvular atrial fibrillation: a practical guide for clinicians

Joanne M Foody

Clin Interv Aging. 2017; 12: 175–187

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279844/

■ II Diretrizes Brasileiras de Fibrilação Atrial

Magalhães, LP et al.

Arq. Bras. Cardiol., Abr 2016, vol.106, no.4, suppl.2, p.1-22

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016003100001&lng=en&nrm=iso